Clear-Cut Medical
Clear-Cut Medical is an Israeli medical device company that develops the ClearCoast™ MRI System, a portable diffusion-weighted MRI for intraoperative breast tumor margin assessment during breast conserving surgery, targeting hospitals and breast surgery centers globally.
- Company typePrivate
- Founded2010
- HeadquartersRehovot, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Clear-Cut Medical does
Clear-Cut Medical Ltd is an Israeli medical device company founded in 2010 and headquartered in Rehovot, Israel, that develops and commercializes the ClearCoast™ MRI System — a portable, real-time diffusion-weighted magnetic resonance imaging (DW-MRI) device used for intraoperative margin assessment of excised breast tissue during breast conserving surgery. The system performs ex-vivo scans of surgically removed tissue outside the patient's body and is classified as a near-patient In-Vitro Diagnostic (IVD) device, providing surgeons with immediate margin status information to identify cancer-positive margins during the initial procedure. The company is led by CEO Hezi Himelfarb (appointed February 2022) and chaired by Michael Berman, former President of Boston Scientific/Scimed; co-founders Eyal Kolka and Erez Golan remain involved as Executive Directors.
Clear-Cut Medical firmographics
Firmographics- Name
- Clear-Cut Medical
- Legal name
- ClearCut Medical Ltd
- Website
- https://clrcut.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clear-Cut Medical is an Israeli medical device company that develops the ClearCoast™ MRI System, a portable diffusion-weighted MRI for intraoperative breast tumor margin assessment during breast conserving surgery, targeting hospitals and breast surgery centers globally.
- Ownership category
- akta.pro rank
Clear-Cut Medical industry classification
Industry- Product category
- Surgical Imaging Systems
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Magnetic Resonance Imaging (MRI) Systems (HLAHABAC)
- akta.pro secondary industry
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)
Keywords
Where Clear-Cut Medical is headquartered
LocationHeadquarters
- HQ city
- Rehovot
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Clear-Cut Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- ClearCoast MRI System Sales: Clear-Cut Medical generates revenue through the sale of its ClearCoast MRI System, a hardware-based medical device. The system is ISO Certified and CE-Marked, enabling commercialization in Europe and other regulated markets. Distribution is handled through channel partners in Europe (pfm medical) and Israel (Gamida medical), with direct enterprise sales in the US and other key markets.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Clear-Cut Medical product offering
Product offeringCore offering
Clear-Cut Medical develops and sells the ClearCoast™ MRI System, a portable, real-time Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) device designed for intraoperative margin assessment of excised breast tumors during Breast Conserving Surgery (BCS). The system operates as a near-patient In-Vitro Diagnostic (IVD) device, performing ex-vivo scans on surgically removed tissue to provide surgeons with immediate margin status information, aiming to reduce the 20-30% re-excision rate associated with positive margins.
Product overview
Clear-Cut Medical offers a single unified medical device product: the ClearCoast™ MRI System. This is a portable, real-time diffusion-weighted magnetic resonance imaging system specifically designed for intraoperative margin assessment of excised breast cancer tumors during breast-conserving surgery. The system operates as a near-patient In-Vitro Diagnostic (IVD) device, performing ex-vivo scans outside the patient's body. It provides breast cancer surgeons with real-time, intuitive margin analysis directly in the operating room, enabling them to identify and address positive margins during the initial surgical procedure rather than requiring follow-up surgeries.
Differentiator
Problem solved
Functional benefit
Brands
- ClearCoast™: Real-time DW-MRI system (Diffusion-Weighted Magnetic Resonance Imaging) that performs intraoperative margin assessment in excised breast tumors during Breast Conserving Surgery (BCS). Also referred to as a near-patient In-Vitro Diagnostic (IVD) system.
Products and services
- ClearCoast™ MRI System A portable, real-time Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) system designed for intraoperative margin assessment of excised breast tumors during Breast Conserving Surgery (BCS). The system performs ex-vivo scans of surgically removed tissue outside the patient's body, providing breast cancer surgeons with immediate, intuitive margin status information to reduce re-excision rates. It is CE-Marked, ISO Certified, and operates as a near-patient In-Vitro Diagnostic (IVD) device.
Quantifiable outcome
- Reduce re-excision rates in breast-conserving surgery by up to 80%
- +2 more outcomes
Companies that use Clear-Cut Medical
Customer profileSegments2 records
Ideal customer profiles1 record
Clear-Cut Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
Clear-Cut Medical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- pfm medicalcorepfm medical serves as the European distributor for the ClearCoast MRI System. They specialize in medical diagnostics products and oncologic margin assessment solutions.
- Gamida medicalcoreGamida medical is the Israeli distributor for the ClearCoast MRI System, handling sales and distribution within the domestic Israeli market.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Clear-Cut Medical competitors and assessment
Company assessmentDirect peers
- Lumicell: Lumicell develops fluorescence-guided intraoperative imaging systems for real-time cancer cell detection during surgery. Direct competitor in the intraoperative margin assessment space with similar clinical workflow and target indications.
- Mauna Kea Technologies (Cellvizio): Mauna Kea Technologies develops confocal laser endomicroscopy (Cellvizio) for in-vivo and ex-vivo cellular-level imaging during surgery. Direct peer offering real-time intraoperative tissue characterization for cancer margin assessment.
- Perimeter Medical Imaging AI: Perimeter develops AI-powered imaging (OCT) for intraoperative margin assessment in breast-conserving surgery. Direct competitor targeting the same clinical workflow of real-time margin detection during lumpectomy to reduce re-excision rates.
- Endomag: Endomag develops magnetic surgical guidance technologies (Magseed, Magtrace) used in breast-conserving surgery and sentinel lymph node procedures. Direct peer selling to the same breast surgery center customer base with the same lumpectomy workflow.
Broad incumbents
- Philips Healthcare: Philips is a global MRI manufacturer and broad medical imaging incumbent. Clear-Cut's VP R&D previously worked at Philips Healthcare, and Philips represents both a competitive incumbent and a potential strategic channel partner for intraoperative MRI applications.
- Siemens Healthineers: Siemens Healthineers is a global leader in MRI and broader medical imaging. As a broad incumbent with established hospital relationships and MRI service infrastructure, Siemens represents both a potential competitive threat and potential OEM/licensing partner for ClearCoast's portable MRI technology.
- GE HealthCare: GE HealthCare is one of the largest MRI manufacturers globally and a broad incumbent in medical imaging. ClearCoast's ex-vivo MRI positioning potentially overlaps with GE's installed MRI base, and GE's scale and service network represent a competitive threat.
- Hologic: Hologic is a major women's health and breast imaging incumbent offering mammography, biopsy, and breast surgery solutions. Broad incumbent with established hospital relationships that compete for breast surgery capital budgets alongside ClearCoast.
Emerging players
- Sirius Medical (BD): Sirius Medical developed the Pintuition system, a wireless surgical marker localization technology for tumor removal in breast and other cancer surgeries. Emerging player in the breast-conserving surgery workflow with comparable target customers and similar clinical value proposition.
- Vita Imaging: Vita Imaging is developing intraoperative imaging solutions for cancer surgery including the APROSPECT system. Emerging player with similar intraoperative margin assessment mission and comparable early commercial stage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Clear-Cut Medical social profiles
Digital presenceClear-Cut Medical compliance and trust
Trust signalCompliance3 records
Clear-Cut Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clear-Cut Medical leadership team
Management profileNumber of profiles
Profiles11 records
Clear-Cut Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clear-Cut Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clear-Cut Medical
What does Clear-Cut Medical do?
Clear-Cut Medical develops and sells the ClearCoast™ MRI System, a portable, real-time Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) device designed for intraoperative margin assessment of excised breast tumors during Breast Conserving Surgery (BCS). The system operates as a near-patient In-Vitro Diagnostic (IVD) device, performing ex-vivo scans on surgically removed tissue to provide surgeons with immediate margin status information, aiming to reduce the 20-30% re-excision rate associated with positive margins.
Is Clear-Cut Medical a public or private company?
Clear-Cut Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Clear-Cut Medical founded?
Clear-Cut Medical was founded in 2010. It employs 11 to 50 people.
Where is Clear-Cut Medical based?
Clear-Cut Medical is headquartered in Rehovot, Israel, in the Middle East region.
How does Clear-Cut Medical make money?
One revenue line is on record: clearCoast MRI System Sales.
Who are Clear-Cut Medical's main competitors?
Direct peers on record are Lumicell, Mauna Kea Technologies (Cellvizio), Perimeter Medical Imaging AI and Endomag. Broad incumbents are Philips Healthcare, Siemens Healthineers, GE HealthCare and Hologic. Emerging players are Sirius Medical (BD) and Vita Imaging.
Does Clear-Cut Medical have an API?
No public API is recorded for Clear-Cut Medical.
What industry is Clear-Cut Medical in?
Clear-Cut Medical's product category is Surgical Imaging Systems. Its primary akta.pro industry code is HLAHABAC, Magnetic Resonance Imaging (MRI) Systems, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 334510 and its SIC code is 3841.